CDTX logo

Cidara Therapeutics, Inc. (CDTX) Net income

annual net income:

-$170.29M-$145.21M(-578.99%)
December 31, 2024

Summary

  • As of today (September 18, 2025), CDTX annual net profit is -$170.29 million, with the most recent change of -$145.21 million (-578.99%) on December 31, 2024.
  • During the last 3 years, CDTX annual net income has fallen by -$127.82 million (-301.00%).
  • CDTX annual net income is now -12570.46% below its all-time high of -$1.34 million, reached on December 31, 2013.

Performance

CDTX Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCDTXincome statement metrics

quarterly net income:

-$25.72M-$2.24M(-9.53%)
June 30, 2025

Summary

  • As of today (September 18, 2025), CDTX quarterly net profit is -$25.72 million, with the most recent change of -$2.24 million (-9.53%) on June 30, 2025.
  • Over the past year, CDTX quarterly net income has increased by +$68.49 million (+72.70%).
  • CDTX quarterly net income is now -316.17% below its all-time high of $11.90 million, reached on September 30, 2022.

Performance

CDTX quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCDTXincome statement metrics

TTM net income:

-$117.10M+$68.49M(+36.90%)
June 30, 2025

Summary

  • As of today (September 18, 2025), CDTX TTM net profit is -$117.10 million, with the most recent change of +$68.49 million (+36.90%) on June 30, 2025.
  • Over the past year, CDTX TTM net income has dropped by -$2.71 million (-2.37%).
  • CDTX TTM net income is now -16463.22% below its all-time high of -$707.00 thousand, reached on March 31, 2014.

Performance

CDTX TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCDTXincome statement metrics

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

CDTX Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-579.0%+72.7%-2.4%
3 y3 years-301.0%-96.0%-76.7%
5 y5 years-314.4%-40.5%-149.0%

CDTX Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-579.0%at low-316.2%+72.7%-2033.8%+36.9%
5 y5-year-579.0%at low-316.2%+72.7%-2033.8%+36.9%
alltimeall time<-9999.0%at low-316.2%+72.7%<-9999.0%+36.9%

CDTX Net income History

DateAnnualQuarterlyTTM
Jun 2025
-
-$25.72M(+9.5%)
-$117.10M(-36.9%)
Mar 2025
-
-$23.48M(-55.2%)
-$185.59M(+9.0%)
Dec 2024
-$170.29M(+579.0%)
-$52.37M(+237.1%)
-$170.29M(+35.0%)
Sep 2024
-
-$15.54M(-83.5%)
-$126.10M(+10.2%)
Jun 2024
-
-$94.21M(+1052.1%)
-$114.39M(+334.2%)
Mar 2024
-
-$8.18M(-0.0%)
-$26.35M(+66.8%)
Dec 2023
-$25.08M(-25.3%)
-$8.18M(+114.0%)
-$15.79M(-25.5%)
Sep 2023
-
-$3.82M(-38.0%)
-$21.21M(+286.4%)
Jun 2023
-
-$6.17M(-359.4%)
-$5.49M(-55.9%)
Mar 2023
-
$2.38M(-117.5%)
-$12.44M(-62.4%)
Dec 2022
-$33.58M(-20.9%)
-$13.60M(-214.3%)
-$33.10M(-8.8%)
Sep 2022
-
$11.90M(-190.7%)
-$36.31M(-45.2%)
Jun 2022
-
-$13.12M(-28.2%)
-$66.29M(+49.5%)
Mar 2022
-
-$18.28M(+8.8%)
-$44.35M(-0.0%)
Dec 2021
-$42.47M(-43.3%)
-$16.80M(-7.1%)
-$44.36M(-9.8%)
Sep 2021
-
-$18.08M(-305.0%)
-$49.19M(+0.9%)
Jun 2021
-
$8.82M(-148.2%)
-$48.74M(-35.8%)
Mar 2021
-
-$18.29M(-15.4%)
-$75.86M(+1.3%)
Dec 2020
-$74.87M(+82.2%)
-$21.63M(+22.7%)
-$74.87M(+11.3%)
Sep 2020
-
-$17.63M(-3.7%)
-$67.26M(+43.0%)
Jun 2020
-
-$18.31M(+5.8%)
-$47.03M(+11.3%)
Mar 2020
-
-$17.30M(+23.4%)
-$42.28M(+1.8%)
Dec 2019
-$41.09M
-$14.02M(-640.4%)
-$41.54M(+4.2%)
DateAnnualQuarterlyTTM
Sep 2019
-
$2.60M(-119.2%)
-$39.85M(-28.9%)
Jun 2019
-
-$13.55M(-18.2%)
-$56.07M(-18.9%)
Mar 2019
-
-$16.56M(+34.2%)
-$69.16M(-0.3%)
Dec 2018
-$69.34M(+24.4%)
-$12.34M(-9.4%)
-$69.34M(-1.5%)
Sep 2018
-
-$13.62M(-48.9%)
-$70.43M(+2.0%)
Jun 2018
-
-$26.64M(+59.0%)
-$69.07M(+16.9%)
Mar 2018
-
-$16.75M(+24.7%)
-$59.08M(+6.0%)
Dec 2017
-$55.73M(+15.7%)
-$13.43M(+9.6%)
-$55.73M(-1.7%)
Sep 2017
-
-$12.26M(-26.4%)
-$56.69M(+0.1%)
Jun 2017
-
-$16.64M(+24.2%)
-$56.66M(+9.4%)
Mar 2017
-
-$13.40M(-6.9%)
-$51.77M(+7.5%)
Dec 2016
-$48.16M(+49.6%)
-$14.39M(+17.7%)
-$48.16M(+10.4%)
Sep 2016
-
-$12.23M(+4.0%)
-$43.64M(+7.5%)
Jun 2016
-
-$11.76M(+20.1%)
-$40.59M(+15.2%)
Mar 2016
-
-$9.79M(-0.8%)
-$35.24M(+9.5%)
Dec 2015
-$32.19M(+170.7%)
-$9.87M(+7.6%)
-$32.19M(+19.3%)
Sep 2015
-
-$9.17M(+43.0%)
-$26.97M(+27.7%)
Jun 2015
-
-$6.41M(-4.8%)
-$21.12M(+17.8%)
Mar 2015
-
-$6.74M(+44.9%)
-$17.92M(+50.7%)
Dec 2014
-$11.89M(+785.0%)
-$4.65M(+40.1%)
-$11.89M(+64.2%)
Sep 2014
-
-$3.32M(+3.1%)
-$7.25M(+84.5%)
Jun 2014
-
-$3.22M(+355.3%)
-$3.93M(+455.3%)
Mar 2014
-
-$707.00K
-$707.00K
Dec 2013
-$1.34M
-
-

FAQ

  • What is Cidara Therapeutics, Inc. annual net profit?
  • What is the all time high annual net income for Cidara Therapeutics, Inc.?
  • What is Cidara Therapeutics, Inc. annual net income year-on-year change?
  • What is Cidara Therapeutics, Inc. quarterly net profit?
  • What is the all time high quarterly net income for Cidara Therapeutics, Inc.?
  • What is Cidara Therapeutics, Inc. quarterly net income year-on-year change?
  • What is Cidara Therapeutics, Inc. TTM net profit?
  • What is the all time high TTM net income for Cidara Therapeutics, Inc.?
  • What is Cidara Therapeutics, Inc. TTM net income year-on-year change?

What is Cidara Therapeutics, Inc. annual net profit?

The current annual net income of CDTX is -$170.29M

What is the all time high annual net income for Cidara Therapeutics, Inc.?

Cidara Therapeutics, Inc. all-time high annual net profit is -$1.34M

What is Cidara Therapeutics, Inc. annual net income year-on-year change?

Over the past year, CDTX annual net profit has changed by -$145.21M (-578.99%)

What is Cidara Therapeutics, Inc. quarterly net profit?

The current quarterly net income of CDTX is -$25.72M

What is the all time high quarterly net income for Cidara Therapeutics, Inc.?

Cidara Therapeutics, Inc. all-time high quarterly net profit is $11.90M

What is Cidara Therapeutics, Inc. quarterly net income year-on-year change?

Over the past year, CDTX quarterly net profit has changed by +$68.49M (+72.70%)

What is Cidara Therapeutics, Inc. TTM net profit?

The current TTM net income of CDTX is -$117.10M

What is the all time high TTM net income for Cidara Therapeutics, Inc.?

Cidara Therapeutics, Inc. all-time high TTM net profit is -$707.00K

What is Cidara Therapeutics, Inc. TTM net income year-on-year change?

Over the past year, CDTX TTM net profit has changed by -$2.71M (-2.37%)
On this page